This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

  • WHO Issues Policy Brief on HIV Prevention Among Transgender Populations
    This new technical brief summarizes essential information and existing World Health Organization (WHO) recommendations for HIV prevention, diagnosis, treatment and care among transgender populations. The 2011 WHO guidance, Prevention and Treatment of HIV and Other ...More
    2 weeks ago Posted in News
  • Self-Testing Helps Combat HIV in Adolescents
    Today only half of people living with HIV are aware of their status. This testing gap, coupled with the importance of early treatment for HIV, is driving interest in of the role of self-testing for HIV. ...More
    2 weeks ago Posted in News
  • New Drug Combination Treats Hepatitis C Patients Also Infected With HIV
    Roughly 20 percent to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV). Both bloodborne viruses share the same modes of transmission, but many HCV medications currently have significant limitations due to ...More
    2 weeks ago Posted in News
  • Screening in Pregnancy is Key to Eliminating Mother-to-Child HIV Transmission
    Canada has almost eliminated mother-to-child HIV transmission, known as vertical transmission, in recent years by ensuring that all women have the opportunity to be screened for HIV in pregnancy and that women with the disease receive treatment before giving birth. In 2014, ...More
    2 weeks ago Posted in News
  • Tracing the Evolution of a Drug-Resistant Pathogen
    To fight a pathogen that’s highly resistant to antibiotics, first understand how it gets that way. Klebsiella pneumoniae strains that carry a particular enzyme are known for “their ability to survive any antibiotics you throw at them,” says Corey Hudson of ...More
    3 weeks ago Posted in News
  • Expert Says Comprehensive Global Prevention Can End HIV/AIDS Pandemic
    Although much progress has been made in combating the global HIV/AIDS pandemic, to halt new infections and end the pandemic, a combination of non-vaccine and vaccine prevention modalities will be needed. Even with these tools, significant implementation gaps must be closed, ...More
    3 weeks ago Posted in News
  • Study Finds PrEP Use Feasible Among High-Risk Groups in Community Settings
    A majority of men who have sex with men (MSM) and transgender women (TGW) at high risk for HIV infection took anti-HIV medication for pre-exposure prophylaxis (PrEP), most of the time, in a multi-site U.S. study examining use of this HIV prevention strategy outside of a ...More
    3 weeks ago Posted in News
  • Adjuvants Improve Immune Response to H7N9 Flu Vaccine
    In a phase 2 trial that included nearly 1,000 adults, the AS03 and MF59 adjuvants (a component that improves immune response of inactivated influenza vaccines) increased the immune responses to two doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted ...More
    3 weeks ago Posted in News
  • NIAID Research Could Aid Development of a Universal Flu Vaccine
    A vaccine that protects against a wide variety of influenza viruses (a so-called universal flu vaccine) is a critical public health goal given the significant rates of illness and death caused by seasonal influenza and the potentially devastating effects of a pandemic ...More
    3 weeks ago Posted in News
  • Sweet Revenge: A Synthetic Sugar Could Fight Superbugs
    A special type of synthetic sugar could be the latest weapon in the fight against superbugs. A team of scientists from the University of Queensland and Queensland biotechnology company Alchemia have discovered a potential new class of antibiotics inspired by sugar molecules ...More
    3 weeks ago Posted in News